Metabolic syndrome in the Philippine general population: prevalence and risk for atherosclerotic cardiovascular disease and diabetes mellitus

Free accessResearch articleFirst published online March, 2008

Metabolic syndrome in the Philippine general population: prevalence and risk for atherosclerotic cardiovascular disease and diabetes mellitus

, , [...], and

Volume 5, Issue 1https://doi.org/10.3132/dvdr.2008.007

Abstract

The objectives of this study were to determine the prevalence of metabolic syndrome (MS) and its component risk factors among Filipinos using three sets of criteria and to evaluate the association between MS and atherosclerotic cardiovascular disease and diabetes mellitus. The study utilised a multi-staged cluster sampling design.

The prevalence of MS was found to be 11.9% by National Cholesterol Education Program/Adult Treatment Panel (NCEP/ATP III) criteria, 14.5% by International Diabetes Federation (IDF) criteria and 18.6% by NCEP/ATP III criteria modified by the American Heart Association/National Heart, Lung and Blood Institute (NCEP/ATP III-AHA/NHLBI) criteria. Low levels of high-density lipoprotein cholesterol (HDL-C) occurred in 60.2% of men and 80.9% of women. Abdominal obesity was noted in 17.7% of men and 35.1% of women. Blood pressure (BP) ≥ 130/85 mmHg was seen in 33.3%, hypertriglyceridaemia in 20.6% and fasting blood sugar ≥ 100 mg/dL (5.55 mmol/L) in 7.1%. Age-adjusted odds ratios showed that MS, by all three definitions, predisposed an individual to diabetes mellitus (DM) and stroke while MS by the IDF definition predisposed an individual to myocardial infarction (MI). Individuals with MS did not have a significant predisposition to angina and peripheral artery disease (PAD).

Thus, the metabolic syndrome is common in Filipinos, with low HDL-C as the most prevalent component. The metabolic syndrome predisposes to diabetes mellitus and stroke, with a tendency to MI using the IDF criteria.

Keywords

atherosclerotic disease diabetes mellitus metabolic syndrome

References

1.

1. National Cholesterol Education Program Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (ATP III) . Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002;106:3143–421.

2.

2. Grundy SM , Brewer HB Jr , Cleeman JI , Smith SC Jr , Lenfant C . American Heart Association: National Heart Lung and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 2004;9:433–8.

3.

3. Onat A , Ceyhan K , Basar O , Erer B , Toprak S , Sansoy V . Metabolic syndrome: major impact on coronary risk in a population with low cholesterol levels – a prospective and cross-sectional evaluation. Atherosclerosis 2002;165:285–92.

4.

4. McNeill AM , Rosamond WD , Girman CJ et al. The metabolic syndrome and 11-year risk of incident cardiovascular disease in the atherosclerosis risk in communities study. Diabetes Care 2005;28:385–90.

5.

5. Girman CJ , Rhodes T , Mercuri M et al. 4S Group and the AFCAPS/TexCAPS Research Group: The metabolic syndrome and the risk of major coronary events in the Scandinavian Simvastatin Survival Study (4S) and the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS). Am J Cardiol 2004;93:136–41.

6.

6. Stern MF , Williams K , Gonzalez-Villapando C , Hunt KJ , Haffner SM . Does the metabolic syndrome improve identification of individuals at risk of type 2 diabetes and/or cardiovascular disease. Diabetes Care 2004;27:2676–81.

7.

7. Sattar N , Gaw A , Scherbakova O et al. Metabolic syndrome with and without C reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study. Circulation 2003;108:414–19.

8.

8. Resnick HE , Jones K , Ruotolo G et al. Strong Heart Study: Insulin resistance, the metabolic syndrome, and risk of incident cardiovascular disease in non-diabetic American Indians: the Strong Heart Study. Diabetes Care 2003;26:861–7.

9.

9. Laaksonen DE , Lakka HM , Niskanen LK , Kaplan GA , Salonen JT , Lakka TA . Metabolic syndrome and development of diabetes mellitus: application and validation of recently suggested definitions of metabolic syndrome in a prospective cohort study. Am J Epidemiol 2002;156:1070–7.

10.

10. Punzalan FE , Sy RG . Prevalence of metabolic syndrome among Filipinos. In: International Congress Series 1262 Atherosclerosis XIII, XIII International Symposium on Atherosclerosis of the International Atherosclerosis Society, Kyoto, Japan 2003;442–5.

11.

11. Ford E , Giles W , Dietz W . Prevalence of metabolic syndrome among US adults. JAMA 2002;287:356–9.

12.

12. Ford ES , Giles WH , Mokdad AH . Increasing prevalence of the metabolic syndrome among US adults. Diabetes Care 2004;27:2444–9.

13.

13. Dans A , Morales D , Velandria F et al. for the NNHeS: 2003 Group. National Nutrition and Health Survey: atherosclerosis-related diseases and risk factors. Philipp J Int Med 2005;43:103–15.

14.

14. Expert Panel on the Detection, Evaluation and Treatment of High Blood Cholesterol in Adults . Executive Summary of the Third Report on the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001;265:2486–97.

15.

15. Alberti, KG , Zimmet P , Shaw J . IDF Epidemiology Task Force Consensus Group. The metabolic syndrome – a new worldwide definition. Lancet 2005;366:1059–62.

16.

16. Grundy SM , Cleeman II , Daniels SR et al. Diagnosis and management of the metabolic syndrome: Statement of the American Heart Association and National Heart Lung and Blood Institute. Circulation 2005;112:2735–52.

17.

17. Araneta MR , Wingard D , Barrett-Connor E . Type 2 diabetes and metabolic syndrome in Filipina-American Women. Diabetes Care 2002;25:494–9.

18.

18. Resnick HE on behalf of the Strong Study Heart Investigators . Metabolic syndrome in American Indians. Diabetes Care 2002;25:1246–7.

19.

19. Meigs J , Wilson P , Nathan D , D'Agostino R , Williams K , Haffner S . Prevalence and characteristics of the metabolic syndrome in the San Antonio Heart and Framingham Offspring Studies. Diabetes 2003;52:2160–7.

20.

20. Jaber L , Brown M , Hammad A , Zhu Q , Herman W . The prevalence of metabolic syndrome among Arab Americans. Diabetes Care 2004;27:234–8.

21.

21. Tan CE , Ma S , Wai D , Chew SK , Tai ES . Can we apply the National Cholesterol Education Program Adult Treatment Panel definition of the metabolic syndrome to the Asians? Diabetes Care 2004;27:1182–6.

22.

22. Kesteloot H , Lee CS , Park HM et al. A comparative study of serum lipids between Belgium and Korea. Circulation 1982;65:795–9.

23.

23. Knuiman JT , West CE , Burema J . Serum total and high density lipoprotein cholesterol concentrations and body mass index in adult men from 13 countries. Am J Epidemiol 1982;116:631–2.

24.

24. Simons LA . Interrelations of lipids and lipoproteins with coronary artery disease mortality in 19 countries. Am J Cardiol 1986;57:5G–10G.

25.

25. Bruckert E . Epidemiology of low HDL-cholesterol: results of studies and surveys. Eur Heart J Suppl 2006;8:F23–F29.

26.

26. Kim SM , Han JH , Park HS . Prevalence of low HDL-cholesterol levels and associated factors among Koreans. Circulation 2006;70:820–6.

27.

27. Park JE . Recent epidemic of metabolic syndrome in Korea. Unpublished. Abstract of the 39th Annual Scientific Meeting of the Japan Atherosclerosis Society p166, Osaka, Japan. July 13–15, 2007.

28.

28. Gami A , Brandi W , Howard D et al. Metabolic syndrome and risk of incident cardiovascular events and death. J Am Coll Cardiol 2007;49:403–14.

29.

29. Kahn R, Buse J, Ferrannini E, Stern M, American Diabetes Association, European Association for the Study of Diabetes . The Metabolic Syndrome: Time for a critical appraisal: Joint Statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2005;28:2289–304.

30.

30. Lakka HM , Laaksonen DE , Lakka TA et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 2002;21:2709–16.

31.

31. Yusuf S, Hawken S, Ounpuu S, Dans A on behalf of the INTERHEART Study Investigators . Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART STUDY): case-control study. Lancet 2004;364:937–52.

32.

32. Bruno G , Merletti F , Biggeri A et al. Casale Monferrato Study: Metabolic syndrome as a predictor of all-cause and cardiovascular mortality in type 2 diabetes: the Casale Monferrato Study. Diabetes Care 2004;27:2689–94.

33.

33. Marroquin OC , Kip KE , Kelley DE et al. Women's Ischemia Syndrome Evaluation Investigators: Metabolic syndrome modifies the cardiovascular risk associated with angiographic coronary artery disease in women: a report from the Women's Ischemia Syndrome Evaluation. Circulation 2004;109:714–21.